Literature DB >> 6615752

Comparative study of the intraocular pressure effects of fluorometholone 0.1% versus dexamethasone 0.1%.

A O Akingbehin.   

Abstract

The intraocular pressure effect of fluorometholone 0.1% was compared with that of dexamethasone 0.1% by performing corticosteroid provocative tests on 24 matched pairs of eyes. Fifteen of the 24 dexamethasone treated eyes, 62.5%, showed a change in intraocular pressure greater than 5 mmHg, with mean delta P = 8.58 mmHg and range 0 to +20 mmHg. Only 2 of the 24 fluorometholone treated eyes, 8.3%, showed a change in pressure greater than 5 mmHg, with mean delta P = 2.96 mmHg and range -2 to +14 mmHg. There was a highly statistically significant difference between the intraocular pressure effects of topical dexamethasone and fluorometholone (correlated t test, p less than 0.001). Fluorometholone would appear to be the topical steroid of choice for patients with glaucoma and other known steroid responders when topical steroid treatment is indicated.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6615752      PMCID: PMC1040159          DOI: 10.1136/bjo.67.10.661

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  12 in total

1.  Penetration of fluorometholone into the cornea and aqueous humor.

Authors:  A Kupferman; H M Leibowitz
Journal:  Arch Ophthalmol       Date:  1975-06

2.  Clinical studies with a new steroid--fluorometholone.

Authors:  H E Buch; R A Ellis
Journal:  Ann Ophthalmol       Date:  1975-07

3.  Vehicle effects on ocular drug bioavailability i: evaluation of fluorometholone.

Authors:  J W Sieg; J R Robinson
Journal:  J Pharm Sci       Date:  1975-06       Impact factor: 3.534

Review 4.  Acute anterior uveitis and prostaglandins.

Authors:  R A Whitelocke; K E Eakins; A Bennett
Journal:  Proc R Soc Med       Date:  1973-05

5.  Fluorometholone. Anti-inflammatory and intraocular pressure effects.

Authors:  W D Fairbairn; J C Thorson
Journal:  Arch Ophthalmol       Date:  1971-08

6.  Comparative ocular pressure elevation by medrysone, fluorometholone, and dexamethasone phosphate.

Authors:  J S Mindel; H O Tavitian; H Smith; E C Walker
Journal:  Arch Ophthalmol       Date:  1980-09

7.  Corticosteroid-induced ocular hypertension. I. Prevalence in closed-angle glaucoma.

Authors:  A O Akingbehin
Journal:  Br J Ophthalmol       Date:  1982-08       Impact factor: 4.638

8.  Binding of glucocorticoid 21-oic acids and esters to molybdate-stabilized hepatic receptors.

Authors:  H J Lee; H L Bradlow; M C Moran; M R Sherman
Journal:  J Steroid Biochem       Date:  1981-12       Impact factor: 4.292

9.  Inheritance of dexamethasone hypertension and glaucoma.

Authors:  M F Armaly
Journal:  Arch Ophthalmol       Date:  1967-06

10.  Prostaglandin-like activity in ocular inflammation.

Authors:  K E Eakins; R A Whitelocke; A Bennett; A C Martenet
Journal:  Br Med J       Date:  1972-08-19
View more
  12 in total

Review 1.  Locally administered ocular corticosteroids: benefits and risks.

Authors:  Charles N J McGhee; Simon Dean; Helen Danesh-Meyer
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

2.  Excimer laser PRK and corticosteroid induced IOP elevation: the tip of an emerging iceberg?

Authors:  P S Phelan; C N McGhee; I G Bryce
Journal:  Br J Ophthalmol       Date:  1994-10       Impact factor: 4.638

3.  Effect of topical steroids on recently developed incomplete nasolacrimal duct obstruction: optical coherence tomography study.

Authors:  Min Kyu Yang; Namju Kim; Ho-Kyung Choung; Sang In Khwarg
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-07-24       Impact factor: 3.117

4.  Comparison of the anti-inflammatory effects of fluorometholone 0.1% combined with levofloxacin 0.5% and tobramycin/dexamethasone eye drops after cataract surgery.

Authors:  Pei-Qing Chen; Xue-Mei Han; Ya-Nan Zhu; Jia Xu
Journal:  Int J Ophthalmol       Date:  2016-11-18       Impact factor: 1.779

Review 5.  Clinical Applications of Dexamethasone for Aged Eyes.

Authors:  Beatriz Abadia; Pilar Calvo; Antonio Ferreras; Fran Bartol; Guayente Verdes; Luis Pablo
Journal:  Drugs Aging       Date:  2016-09       Impact factor: 3.923

6.  Effect of dexamethasone 0.1% and prednisolone acetate 1.0% eye drops on the blood-aqueous barrier after cataract surgery: a controlled randomized fluorophotometric study.

Authors:  M Diestelhorst; F Aspacher; W Konen; G K Krieglstein; R D Hilgers
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

Review 7.  Glucocorticoid therapy and ocular hypertension.

Authors:  Adnan Dibas; Thomas Yorio
Journal:  Eur J Pharmacol       Date:  2016-07-05       Impact factor: 4.432

8.  Topical fluorometholone treatment for ocular dryness in patients with Sjögren syndrome: a randomized clinical trial in China.

Authors:  Tong Lin; Lan Gong
Journal:  Medicine (Baltimore)       Date:  2015-02       Impact factor: 1.889

9.  Intraocular pressure effects of common topical steroids for post-cataract inflammation: are they all the same?

Authors:  Uwe Pleyer; Paul G Ursell; Paolo Rama
Journal:  Ophthalmol Ther       Date:  2013-09-17

10.  Severe Corticosteroid-Induced Ocular Hypertension Requiring Bilateral Trabeculectomies in a Patient with Takayasu's Arteritis.

Authors:  Anna Maria Gruener; Pranev Sharma; Sally Ameen; Faisal Ahmed
Journal:  Case Rep Ophthalmol Med       Date:  2016-11-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.